Dr. Ashkenazy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-2020Fax+1 214-645-2011
Education & Training
University of Texas Southwestern Medical CenterResidency, Ophthalmology, 2016 - 2019
University of Miami Leonard M. Miller School of MedicineClass of 2015
Certifications & Licensure
FL State Medical License 2019 - 2025
TX State Medical License 2022 - 2025- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 18 citationsShort-Term Effects of COVID-19-Related Deferral of Intravitreal Injection VisitsNoy Ashkenazy, Lediana Goduni, William E Smiddy
Clinical Ophthalmology. 2021-02-03 - 3 citationsIris metastasis from breast cancer successfully treated with Abemaciclib and Letrozole.Lediana Goduni, Noy Ashkenazy, Eric Hansen, Aixa Soyano-Muller, Zelia M. Correa
Retinal Cases & Brief Reports. 2021-06-11 - 17 citationsImmunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.Noy Ashkenazy, Carol L. Karp, Gaofeng Wang, Carolina Mercado Acosta, Anat Galor
Cornea. 2017-04-01
Press Mentions
Eye Surgery: Why Outcomes Are Less Successful for Black, Hispanic Patients After Retinal Detachment ProcedureMarch 24th, 2023
Short-Term Effects of COVID-19-Related Deferral of Intravitreal Injection VisitsJanuary 11th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
